Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516659 · ClinicalTrials.gov registry record · Phase 2
ETEC Logistics Trial (TREK)
A Phase 2 study of Diarrhea, sponsored by Intercell USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 201
- Enrollment target
- 19
- Study locations
NCT00516659 is a Phase 2 study of Diarrhea that has completed, run by Intercell USA. The registered enrollment target is 201 participants, above the 149-participant average among 24 other Diarrhea trials with a reported enrollment target (35% higher). The trial reports 19 study locations across 16 states.
The verdict
NCT00516659, a Phase 2 study of Diarrhea, has completed, sponsored by Intercell USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 201 participants
- Enrollment target
- 19
- Study locations
Study Summary
This is a multicenter, double-blind, randomized, placebo-controlled field trial to evaluate the epidemiology of natural infection with ETEC occurring after transcutaneous immunization in a field setting.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Heat-Labile Enterotoxin of Escherichia coli (LT)
Study Locations (19)
Texas
- Radiant Research - Dallas
- Breco Research - Houston
- Center for Infectious Diseases, The University of Texas Health Science Center at Houston - Houston
- Radiant Research - San Antonio
California
- West Coast Clinical Trials - Long Beach
Illinois
- Radiant Research - Chicago
Maryland
- Johns Hopkins University, Bloomberg School of Public Health - Baltimore
Minnesota
- Twin Cities Clinical Research - Minneapolis
New Jersey
- Advanced Biomedical Research - Hackensack
New York
- Asthma Allergy & Associates - Ithica
Ohio
- Radiant Research - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00516659
The ClinicalTrials.gov registry entry for NCT00516659 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 149-participant average among 24 other Diarrhea trials with a reported enrollment target (35% higher). The listed sponsor is Intercell USA, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diarrhea appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00516659 reports 19 study locations spanning 16 distinct geographic areas - top geographies include Texas, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT00516659 about?
NCT00516659 is a clinical study titled "ETEC Logistics Trial (TREK)". This is a multicenter, double-blind, randomized, placebo-controlled field trial to evaluate the epidemiology of natural infection with ETEC occurring after transcutaneous immunization in a field setting.
What is the current status of trial NCT00516659?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 201 participants. The study started on 2006-05. Estimated completion is 2007-12.
What conditions does trial NCT00516659 study?
This clinical trial studies the following conditions: Diarrhea.
What interventions are being tested in trial NCT00516659?
The interventions under investigation include: Placebo (BIOLOGICAL), Heat-Labile Enterotoxin of Escherichia coli (LT) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00516659?
This trial is sponsored by Intercell USA, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00516659 being conducted?
This trial has 19 study locations across California, Illinois, Maryland, Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diarrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fecal Microbiota Transplantation for IBS
RECRUITING · Phase 2
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
COMPLETED · Phase 2
-
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
COMPLETED · Phase 2
-
Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.